so you're not angry, you're not angry like strive masiyiwa.eyond anger, then? i think the situation is very concerning, and it's not necessarily about being angry. it is very concerning that because of the situation in india, we are not, as a continent, going to meet our vaccination needs by the end of this year, which was heavily reliant on supplies from the serum institute in india. so i'm deeply concerned with that scenario. all right. so you've talked about how you're looking at other vaccines, notjust astrazeneca, which is produced mostly in india, you've said, and gavi, the international vaccine alliance, which is backing the covax scheme, has also said it's considering a number of options to make up the jab shortfall to lower—income countries, mostly in africa, by building a wider portfolio of 10 to 12 vaccines. is that a good idea, do you think, is that a strategy you back? i think it's a strategy that i believe has been there since the beginning of the initiative, that is the creation of the covax mechanism. what we need now very urge